Bristol Myers Squibb Company: Too Cheap To Ignore | FAST Graphs 

This didb't age well

Think about taxes when trading Stocks. Thats the reason I buy and hold

I do the same thing in my Roth.

We get it, you timed the market perfectly 🙄

Looking at analytical analysis only is useless... As most of the videos on this channel.

@@CroncAstronautHmmm - then why are you here? As a user of Fast Graphs, while I find the videos and the related tool indispensable. I've used the product for several years. My post was to see if I had missed something in liking BMY. Do you have an opinion on BMY?

@@davebean2886 I'm here because i like to read different sources in general. This one, as many others, proves to be a failed assessement. On BMY, yes, I have an opinion. I think it will fall even further in the next 4-6 months, around 35$.

When I think of BMY, I have a picture of a good red wine in my mind. If it doesn't help, maybe the wine does. 😊 Cheers!

Garbage@@mikewu9483

maybe...but three months later it might be at 42 lol...hard to invest in pharma

Thanks for sharing your view. However, it is flawed logic to simply assume a stock is better at a lower price, because you also have to consider it whether fundamentals are changing or not. Nevertheless, in the case of Bristol-Myers I do believe the stock was cheap at $70 and in the long run that will prove to be a good long-term investment. Of course, that also says that buying unit $50 today will also be as you say an opportunity to buy low. Fundamentals matter more than price. Regards, Chuck

Nate, I have a video in the works on MPW. I expect to publish it Tuesday or Wednesday of next week, watch for it. Regards, Chuck

@@FASTgraphs amazing Chuck! Thx for all your works

yes, you could spend hours going through in gathering numbers from other sources. But you enacted the perspective that this offers you in an instant.

@@FASTgraphs that doesn’t change the fact that the numbers are incredibly easy to find. And incredible easy to calculate. After all, we do have formulas that don’t really change. Sure it might take a LITTLE bit more effort to go into the 10-k and divide some numbers or you can easily Google the ebita. It is very intro lvl. If you take any beginner accounting class, they will teach you about the balance sheet, income statement, and statement of cash flows. Im just still confused how you recommend any business but fail to talk about the company. As far as I’m concerned, you have no idea what BMY does and all you know are the numbers. All you do is talk about the ticker. From one ticker to the next. Nothing about the underlying business itself. Nothing about management, new products, innovations…nothing. Have you heard of Peter Lynch? Buy businesses, not tickers. You are 110% just buying tickers that look good.

Chuck read the 10K, etc., but the glaring hole in his analysis is: patent cliff

I’m also a FB-Subscriber; what I do, EVERYTIME - is to Watch/Pause on my iPad, and Emulate on my Desktop Computer - Replicating most of the things that he is demonstrating. Kinesthetic Learning.

Thorough videos such as this provide an enormous due-diligence education. Understanding the quality of a company and its results is a serious undertaking. I am a long-time FG subscriber.

It aged worse now

Crazy. Cause my average price is $56.36 with a yield on cost of 3.83% Glad im raking in more than you on a more expensive price 🙄

BMY (NYSE) $68.48

They don't ring a bell at the top or bottom of the market , but fundamentals do not lie

You don’t say if you are a Subscriber ( I am ); [ ] Under the Gear Tool in the Upper Right Hand Corner - for ‘Graph Settings’ - you can ENTER an Amount in the ‘Performance Results’s On:’ - but THAT amount will be: - for ALL Tickers (just like, ‘Custom Valuation Ratio’) and realize it will be for ALL PERIODS of Analysis - not from the Real Date of your Transaction; HOWEVER [ ] You CAN - Enter (‘Manage your Transactions’ - BUYS and Dividends Re-Invested) under the $ (next to the Gear in the Upper Right) of the Screen; and/OR - IF you have Created a PORTFOLIO in ‘My Portfolios’ - under ‘HOLDINGS’ - Enter or Import Transactions’ - see Tutorials for doing the Import

ALSO, on the Graph - after having Entered your Transaction . . . There will be a Green Dot that SHOWS you Purchase and a Line that Shows your ‘Average Cost’; THERE you can Select your ‘Buy’ and then Select a Future Period of Time on the Price Line to see - ‘Rate of Return’ - Market Value, Growth, Ann ROR (w/out Div), Dividends, MV + Div, Total ROR and Tot Ann ROR for THAT Period.

thats a good idea for a new video

48 today lol...crazy

10 year compounded dividend growth rate is about 7.7% from 08 to 18 which captures growth potential outside of economic downturns and prior to acquisition.

Buy it while you can

@@FASTgraphs Yes but not so great a buy a year ago.

Price is what you pay value is what you get, but you also get the dividend. That's why you need to hold an investment in a dividend paying value stock for at least a business cycle.

David, earnings yield (E/P) is the inverse of the P/E ratio and tells you what return you would receive if you owned 100% of the company and they paid you 100% of their profits. Ben Graham the father of value investing suggested that we should never pay more than 15 times earnings to buy a stock, which represents a 6.67% earnings yield. For most companies, not all but most, that represents a very prudent principal for value investors to adhere to. In other words, what is the minimum return you would be willing to get for the risk you are taking. There is much more to the story, but hopefully this provides some insight. Regards, Chuck

@@FASTgraphs thank you very much

Would be great with an update indeed. I think the forecast going forward have been reduced and there is higher generic erosion than initially thought.

FAST Graphs is a fundamentals analyzer software tool intended for long-term value investing. It is not a market timing or short-term trading software. With that said FAST Graphs is invaluable for BMY.

Even cheaper, if you're prudent long-term investor

Earnings have collapsed therefore, I don't consider MRNA cheap

operating earnings P/E ratio is only 9.37. I think you're looking at gap earnings. The video explained all of that. thanks, Chuck

I respectfully disagree, the principles of accounting, mathematics, and economics are timeless. Valuation is always a function of the future earnings and cash flows the individual company can produce on behalf of its stakeholders.here is the Warren Buffett quote from 1994 that I have adhered to: "“We will continue to ignore political and economic forecasts which are an expensive distraction for many investors and businessmen. Thirty years ago, no one could have foreseen the huge expansion of the Vietnam War, wage and price controls, two oil shocks, the resignation of a president, the dissolution of the Soviet Union, a one-day drop in the Dow of 508 points, or treasury bill yields fluctuating between 2.8% and 17.4%. But surprise-none of these blockbuster events made even the slightest dent in Ben Graham’s investment principles. Nor did they render unsound the negotiated purchases of fine businesses at sensible prices. Imagine the cost to us, if we had let a fear of unknowns cause us to defer or alter the deployment of capital. Indeed, we have usually made our best purchases when apprehensions about some macro event were at a peak. Fear is the foe of the faddist, but the friend of the fundamentalist.”regards, Chuck

@@FASTgraphs 100% agree - the principles of mathematics, accounting and economics are timeless. I'm simply pointing out that your model fails to properly incorporate exactly those things. You base your ASSUMPTIONS on a time series that is incomplete and that you do NOT take into account internal or external WACC. If you want to say that's intentional, that's o.k. Like it or not, rates matter, and inflation matters, and the macroeconomic conditions and long-dated secular trends that drive them matter. You fundamentally misread Buffett and misapply his principles for "macro" events. He is talking about cyclical macro and singular events, not secular trends and cost of capital, both of which he says matter a great deal in determining what an attractive valuation is.

@@biscaynediver we will be adding metrics utilizing WACC soon, currently in development. Nevertheless, what you our calling my model is simply reporting what leading analysts following the company are forecasting. The historical data simply cannot be argued with because it is factual as presented. The forecasting data is provided by leading analysts reporting to FACTSET. if their forecast change, it will be reflected in FG in a timely manner. The point is micro analysis rather than macro which does not necessarily universally apply.

@@FASTgraphs I never said the historical data was not factual. I said the dataset is for too short a time-series, suffers from recency bias, and was generated during an entirely different cost of capital macro-environment, and therefore is a poorly matched dataset. Why not offer a dataset for other periods and let people choose? The 20-year period you use is an aberration in the larger historical record, and more importantly, is no longer applicable. As for the analyst data, I think people know that it is of notoriously poor predictive value at inflection points. You are merely providing the data - nothing wrong with that, other than if you don't offer commentary about how wrong that data turns out to be at market inflections, always badly behind the curve in both accelerating growth and expanding multiple environments and decelerating growth and multiple contraction environments. Everyone inside the industry knows the chinese wall is a chimera and that analyst forecast data is heavily influenced by the need for investment banking relationships and access to management. There is going to be a lot of value-trap wealth destruction in the coming years because people don't understand and poorly forecast the relationship between cost of capital and multiples, and because although bear markets are characterized first by having high-flying, high multiple stocks taken out and shot, they don't end until the "value" part of the market also gets crushed, and until there is a realization that it isn't just high-multiple, high-growth rate stocks that have their revenue growth rates and net margins contract and normalize, it is "safe-haven" names as well. We were at peak corporate net margins. We are not yet near the median of the range, much less the overshoot that normally happens."

@@biscaynediver "We are not yet near the median of the range, much less the overshoot that normally happens". Says who ? You just said that analysts are not reliable. Which means that you know better than them. Pretending to have a cristal ball is a dangerous game, and needs to be done with a lot of precaution. If your predictions are so much better than the consensus, I guess you must be very wealthy, can you tell us more about that? Do you manage your own fund, or are you the analyst of the year at Goldman ? Besides ; you are broadly generalizing the impact of inflation on earnings. Software companies, for instance, are proven to adjust their prices smoothly in inflationary periods. Same with.... Pharma, relevant to this video.

Richard:I agree with all the names you mentioned and have produced videos on all of them. One caveat, just because a company hits new Low's does not necessarily mean that it is undervalued. You have to look at valuation in relation to fundamentals like earnings and cash flows not just price action. Regards, Chuck P. S. I'm glad you like the videos.

@@FASTgraphs I fully agree that new lows don't necessarily mean that they are a good value, but in this case the stocks I mentioned are. As a Fastgraphs subscriber I do appreciate it's usefulness in determining fair value and ensuring a measure of safety when researching potential stock additions to my investment portfolio. Thank you again

I don't like pharma companies. Too much risk on both the product pipeline and liability.

I believe that Chuck is Double Sharing this on both FAST graphs and Dividend Kings by THEIR Request; Here was the Introduction in Yesterday's DK Article on Seeking Alpha, "Most Requested Stocks by Dividend Kings and iREIT Subscribers" . . . "The stocks I was asked to cover are the ones most asked for based on a survey of you the subscribers of Dividend Kings and iREIT. The list of 5 stocks that you asked to be covered will be presented over a series of 5 additional videos.

I would avoid T, VZ and MMM personally. All the rest are fair game.